Cell membrane-camouflaged nanocarriers: A cutting-edge biomimetic technology to develop cancer immunotherapy

被引：1
作者：
Samanta, Rajkumar [1 ,2 ]
Haldar, Niladri [1 ,2 ]
Pamecha, Anchal [3 ]
Gajbhiye, Virendra [1 ,2 ]
机构：
[1] Agharkar Res Inst, Nanobiosci, 411004 AC, Pune 411004, India
[2] Savitribai Phule Pune Univ, Pune 411007, India
[3] Agharkar Res Inst, Nanobiosci Grp, Pl Work, Pune, India
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2025年 / 672卷
关键词：
Biomimetic; Cell membrane-coated nanoparticles; Cancer immunity cycle; Cancer Immunotherapy; Immune checkpoint block; Tumor vaccine; COATED NANOPARTICLES; MACROPHAGE-MEMBRANE; MAGNETIC NANOPARTICLES; ANTICANCER VACCINATION; DRUG-DELIVERY; NANOVACCINE; SYSTEM; TOXINS; DOX;
D O I：
10.1016/j.ijpharm.2025.125336
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The development and growth of many diseases are significantly influenced by immune dysregulation. Similarly, uncontrolled tumor growth occurs in cancer because the immune system is unable to identify and eradicate cancer cells. Therefore, to address this issue, cancer immunotherapy plays a crucial role in detecting tumors and inhibiting their growth. This immune-oncotherapy has gained significant interest over the last decade because of its relevant success in biomedical applications. The fundamental goal of immunotherapy in the war against cancer is to develop potent immunotherapies that have minimal side effects and excellent tumor selectivity. To develop these characteristics, nanotechnology offered promising opportunities for cancer immunotherapy. Cell membrane-coated nanoparticles (CMNPs) have recently evolved, which has a tremendous advantage over other nanoparticles (NPs). The CMNPs can be formed by wrapping cell membranes, which can camouflage the specific cell type, allowing these NPs to survive like "self" during blood circulation and escape immune cell capture. These provide NPs with increased biocompatibility, minimal immunogenicity, longer circulation, and targeted tumor therapy. These advantages have made CMNPs a potential delivery vehicle for immunostimulatory drugs, which can induce immunological responses and lead to cancer immunotherapy. Surface modification of CMNPs using cutting-edge genetic engineering techniques revolutionizes cancer immunotherapy to produce new nano- formulations with greater effectiveness. In this review, we briefly discuss the relationship between cancer and the immune system, various techniques of CMNPs synthesis, and the use of naturally occurring and genetically modified CMNPs for cancer immunotherapy.
引用
收藏
页数：27
相关论文
共 135 条
  • [1] An D., Et al., Boosting piezocatalytic performance of BaTiO3 by tuning defects at room temperature, Nanomaterials, 14, 3, pp. 1-13, (2024)
  • [2] Bahmani B., Et al., Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors, Nat. Commun., 12, 1, pp. 1-12, (2021)
  • [3] Ben-Akiva E., Meyer R.A., Yu H., Smith J.T., Pardoll D.M., Green J.J., Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal, Sci. Adv., 6, 16, pp. 1-9, (2020)
  • [4] 8, 2, (2022)
  • [5] Breckpot K., Escors D., “Dendritic cells for active anti-cancer immunotherapy: Targeting activation pathways through genetic modification,” Endocrine, Metab. Immune Disord. - Drug Targets, 9, 4, pp. 328-343, (2009)
  • [6] Cai D., Et al., Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and paclitaxel for the combination of chemo/magnetocaloric therapy on MDA-MB-231 cells, Sci. Rep., 9, 1, pp. 1-10, (2019)
  • [7] Cailing Chen S.F., Meiyu Song, Yangyang Du, Ying Yu, Chunguang Li, Yu Han, Fei Yan, Zhan Shi, “Tumor-associated-macrophage-membrane-coated nanoparticles for improved photodynamic immunotherapy, Nano Lett., 21, 13, pp. 5522-5531, (2021)
  • [8] Cao H., Et al., Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer, ACS Nano, 10, 8, pp. 7738-7748, (2016)
  • [9] Chang R.B., Beatty G.L., The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance, J Leukoc Biol., 108, 1, pp. 363-376, (2020)
  • [10] Chen Q., Et al., Cancer cell membrane ‑ coated nanoparticles for bimodal imaging ‑ guided photothermal therapy and docetaxel ‑ enhanced immunotherapy against cancer, J. Nanobiotechnology, 19, December, pp. 1-22, (2021)
12345678910